Laboratory Market Reaches US$3.1 Billion, Indonesian Labs Boost Industrial Competitiveness
Ahead of the return of the biennial Lab Indonesia exhibition, laboratories are increasingly regarded as crucial scientific infrastructure supporting research, innovation, and industrial development across various sectors. In Indonesia, demand for laboratory services and technology continues to rise alongside the growth of the manufacturing industry and various national programmes aimed at improving production quality, quality control, and compliance with industry standards.
Currently, there are more than 10,500 public health laboratories across Indonesia, while the national clinical laboratory market is projected to reach over US$3.1 billion by 2027.
In this context, Lab Indonesia 2026 will be held again from 15–17 April at Indonesia Convention Exhibition (ICE) BSD City, under the theme “Shaping the Future of Indonesia’s Laboratory Industry: Innovation, Standards, and Global Competitiveness”. Entering its eighth edition, Lab Indonesia has evolved into an exhibition covering the laboratory industry sector, including medical, pharmaceutical, educational, and scientific research chemicals.
More than just an exhibition, this event also serves as a strategic business platform that brings together innovations, discoveries, and laboratory technologies from various countries to meet the evolving needs of the industry.
This development aligns with the growth of the global laboratory technology industry, estimated to increase from US$258.71 billion in 2023 to around US$468.15 billion by 2032. In this increasingly competitive industrial landscape, collaboration between industry, regulators, and academic institutions is becoming ever more important to drive innovation and enhance national competitiveness.
With the relocation to ICE BSD City, Lab Indonesia 2026 will feature a larger exhibition scale on an area of more than 14,500 square metres, targeting over 300 participating companies (exhibitors) and around 15,000 professional visitors from various industrial sectors. Four international pavilions from China, Germany, Korea, and Malaysia are also scheduled to participate, joined by companies from 16 countries/regions, including the United States, China, Finland, Hong Kong, India, the United Kingdom, Italy, Japan, Germany, South Korea, Malaysia, France, Singapore, Sweden, Switzerland, and Taiwan.
Kristi Wulandari, Deputy Event Director of PT Pamerindo Indonesia, the organiser of Lab Indonesia 2026, expressed optimism about this year’s event, particularly with the venue change allowing for an increased scale of industry participation.
“The significant participation of international companies shows that Indonesia is increasingly viewed as an important market for the laboratory technology industry. We hope Lab Indonesia can become a space for collaboration that connects global innovations with the needs of industry and research in Indonesia,” she stated in a press release on Thursday (2/4/2026).
The presence of companies from various countries positions Lab Indonesia as one of the key meeting points for industry players to explore investment opportunities, expand business networks, and understand the dynamics of the evolving national laboratory market.
The high interest from international companies is also reflected in the satisfaction levels of participants from previous editions. “We believe that the future of Indonesian laboratories is determined by the ability to deliver accurate, reliable results in line with regulatory standards, while also improving efficiency and adopting cutting-edge analytical technologies. Through our participation in Lab Indonesia 2026, we want to demonstrate our commitment to this transformation,” said Saptogiri, Managing Director of PT Wiralab Analitika Solusindo.